Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis.
Sahmin LeeSeung-Ah LeeBongkun ChoiYe-Jee KimSoo Jin OhHong-Mi ChoiEun Kyoung KimDae-Hee KimGoo Yeong ChoJong-Min SongSeung Woo ParkDuk-Hyun KangJae-Kwan SongPublished in: Heart (British Cardiac Society) (2020)
DPP-4 inhibitors with favourable pharmacokinetic and pharmacodynamic properties were associated with lower risk of AS progression. These results should be considered in the preparation of randomised clinical trials on the repositioning of DPP-4 inhibitors.